UT Southwestern hub for cancer clinical trials
UT Southwestern NCI National Clinical Trials Network LAPS
This program connects adults with cancer to a wide range of NCI-supported clinical trials through UT Southwestern.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11291262 on NIH RePORTER |
What this research studies
If you join, UT Southwestern acts as a lead site that helps adults with many types of cancer find and enroll in National Clinical Trials Network (NCTN) studies. The site coordinates care across main and outreach clinics, including new outpatient centers and a safety-net location in South Dallas. Investigators at the center use imaging, artificial intelligence tools, and partnerships in public health and biomedical engineering to support trial procedures and follow-up. By participating you may get access to experimental therapies, close monitoring, and the chance to contribute to research that can change practice.
Who could benefit from this research
Good fit: Adults (generally 21 and older) with a cancer diagnosis whose medical condition matches one of the active NCTN trial eligibility criteria at UT Southwestern are the ideal candidates.
Not a fit: People without cancer, most pediatric patients under 21, or adults whose disease does not match any available trial criteria or who cannot come to UT Southwestern are unlikely to benefit from this program.
Why it matters
Potential benefit: This program could give patients access to new treatment options, expert multidisciplinary care, and opportunities to influence cancer-care guidelines.
How similar studies have performed: NCTN site programs have a strong track record of enrolling patients and producing practice-changing results, and UT Southwestern previously enrolled hundreds of patients and contributed to policy and guideline changes.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Gerber, David Eric — Ut Southwestern Medical Center
- Study coordinator: Gerber, David Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.